SpectrumX Holdings UK Ltd is a leader in patented formulations of HOCl (Hypochlorous Acid).
Through its partnership with Spectrum Antimicrobials, California, USA the company holds various licenses for the use of its unique formulations in the United Kingdom and Europe.
Historically HOCl has been overlooked by “big pharma” due to the fact HOCl has never previously been able to be patent protected as well as the limitation of traditional production methods. Both of these challenges have been overcome by SpectrumX.
The company is currently raising pre-IPO capital.
source